Lumis Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 3.02 Cr
as on 23-10-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.40 Cr
as on 23-10-2024
- Satisfied Charges ₹ 16.35 Cr
as on 23-10-2024
- Revenue 21.74%
(FY 2023)
- Profit -4.40%
(FY 2023)
- Ebitda -5.78%
(FY 2023)
- Net Worth 19.92%
(FY 2023)
- Total Assets 23.21%
(FY 2023)
About Lumis Biotech
The Corporate was formerly known as Khandelwal Medi Care Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.02 Cr.
The company currently has active open charges totaling ₹5.40 Cr. The company has closed loans amounting to ₹16.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dwarka Somani, Mahendranath Khandelwal, and Gaurav Khandelwal serve as directors at the Company.
- CIN/LLPIN
U24239MH1994PTC083976
- Company No.
083976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Lumis Biotech Private Limited offer?
Lumis Biotech Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Enzymes, Fruit & Vegetable Processing Machine, Juice Extractor, Dough Conditioners, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Textile, Dyeing & Finishing Chemical, Textile Chemical, Bromelain.
Who are the key members and board of directors at Lumis Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dwarka Somani  | Director | 01-Apr-2016 | Current |
| Mahendranath Khandelwal | Director | 22-Dec-2004 | Current |
| Gaurav Khandelwal | Whole-Time Director | 06-Feb-2003 | Current |
Financial Performance and Corporate Structure Insights of Lumis Biotech.
Lumis Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.74% increase. The company also saw a slight decrease in profitability, with a 4.4% decrease in profit. The company's net worth Soared by an impressive increase of 19.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lumis Biotech?
In 2023, Lumis Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stellar Chemical Laboratories Private LimitedActive 37 years 1 monthMahendranath Khandelwal and Gaurav Khandelwal are mutual person
S R Khandelwal And Sons Private LimitedActive 51 years 14 daysMahendranath Khandelwal and Gaurav Khandelwal are mutual person
- Ravisun Creative Promotions Private LimitedActive 34 years 9 months
Dwarka Somani is a mutual person
- Ram Shree Holding Company Private LimitedActive 36 years 1 month
Mahendranath Khandelwal and Gaurav Khandelwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Feb 2017 | ₹5.40 Cr | Open |
Punjab Naional Bank Creation Date: 26 Jun 2008 | ₹1.00 Cr | Satisfied |
Bank Of Baroda Creation Date: 31 May 2006 | ₹6.20 Cr | Satisfied |
How Many Employees Work at Lumis Biotech?
Lumis Biotech has a workforce of 60 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lumis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lumis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
